HALEY HUGHES: Open Payments
NPI 1063109247 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 39 payments from 13 companies in 2025. Trend: 2023 $910 · 2024 $1,023 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $296 |
| AstraZeneca Pharmaceuticals LP | 8 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| Octapharma USA, Inc. | 1 | $96 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| Genentech USA, Inc. | 2 | $53 |
| LEO Pharma Inc. | 2 | $49 |
| Amgen Inc. | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: DUPIXENT, PANZYGA, FASENRA, TEZSPIRE, Xolair, Rhapsido, ADBRY, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
